Innovation Pharmaceuticals Inc (IPIX)

[Truthbythought]

Looks good. Is it just me or every time I see a data set for this trial the numbers change?

Outperforms Dapto on days 2-3. Slightly underperforms Dapto at Day 28. Interesting - wonder if that was just an issue with follow-up (seems likely).

Does anyone recall what the dosing on the Ph2B study is going to be. Seems that ideally we want a shorter dose, but at the HIGH level of dosing of 1 mg/kg for ideal results.

Here's hoping that any history of hypertension is an exclusion criteria. That should take care of the SAE's.